Agenda and minutes

Venue: Committee Room 3 - Senedd. View directions

Contact: Claire Morris 

Media

Senedd.TV: View the webcast

Items
Expected timing No. Item

2.

Transcript

View the meeting transcript (PDF 780KB) View as HTML (424KB)

1.

Introductions, apologies, substitutions and declarations of interest

Minutes:

1.1 The Chair welcomed Members to the meeting.

1.2 Apologies were received from Dawn Bowden AM and Julie Morgan AM.

(09.30 - 10.15)

2.

Use of anti-psychotic medication in care homes - evidence session 9 - Royal College of Occupational Therapists & Royal College of Speech and Language Therapists

Karin Orman, Royal College of Occupational Therapists  

Dr Alison Stroud, Royal College of Speech and Language Therapists

Beth Bowen, Royal College of Speech and Language Therapists

 

Supporting documents:

Minutes:

2.1 The Committee received evidence from representatives of the Royal College of Occupational Therapists and Royal College of Speech and Language Therapists.

(10.20 - 10.50)

3.

Use of anti-psychotic medication in care homes - evidence session 10 - Care Forum Wales

Melanie Minty, Care Forum Wales

Steven Ford, Care Forum Wales

Supporting documents:

Minutes:

3.1 The Committee received evidence from representatives of Care Forum Wales.

4.

Motion under Standing Order 17.42 to resolve to exclude the public from the meeting for the following item of business

Minutes:

4.1 The Committee agreed the motion.

(10.50 - 11.20)

5.

Inquiry into the physical activity of children and young people - inquiry refresh

Supporting documents:

Minutes:

5.1 The Committee had further discussions about its inquiry into the physical activity of children and young people and agreed to issue invites to stakeholders to attend evidence gathering sessions in the spring term.

(11.35 - 12.05)

6.

Use of anti-psychotic medication in care homes - evidence session 11 - Care and Social Services Inspectorate Wales

David Francis, Assistant Chief Inspector, Care and Social Services Inspectorate Wales

Supporting documents:

Minutes:

6.1 The Committee received evidence from representatives of the Care and Social Services Inspectorate Wales.

6.2 David Francis agreed to provide the Committee with a breakdown of the number care homes in Wales which had been closed by CSSIW for poor service provision.

(12.45 - 13.30)

7.

Use of anti-psychotic medication in care homes - evidence session 12 - Cwm Taf University Health Board and Cardiff and Vale University Health Board

Mr John Palmer, Director of Primary, Community and Mental Health, Cwm Taf UHB

Mrs Kim Williams, Consultant Psychologist Older Persons Mental Health, Cwm Taf UHB

Victoria Gimson, Specialist Mental Health Pharmacist, Cardiff and Vale UHB

Candace Rowlands, Cardiff and Vale UHB

Supporting documents:

Minutes:

7.1 The Committee received evidence from representatives of Cwm Taf University Health Board and Cardiff and Vale University Health Board.

(13.35 - 14.20)

8.

Use of anti-psychotic medication in care homes - evidence session 13 - Aneurin Bevan University Health Board and Hywel Dda University Health Board

Claire Aston, Divisional Nurse/Head of Complex Care, Aneurin Bevan UHB

Dr Chineze Ivenso, Old Age Consultant Psychiatrist (Newport Community Mental Health Team), Aneurin Bevan UHB

Sarah Isaac, Senior Pharmacist Manager – Primary Care, Hywel Dda UHB

Sue Stephens, Prescribing Advisor, Hywel Dda UHB

Minutes:

8.1 The Committee received evidence from representatives of Aneurin Bevan University Health Board and Hywel Dda University Health Board.

8.2 Dr Chineze Ivenso agreed to provide the Committee with the findings, so far, of the 2017 audits on the use of antipsychotic medication with patients who have dementia living in care home settings in the Newport borough.

8.3 Both Health Boards agreed to write to the Committee setting out what data on antipsychotic prescribing they believed should be collected nationally to enable health boards to benchmark against other and against NICE standards.

9.

Paper(s) to note

9.1

Use of antipsychotic medication in care homes - additional information from Community Pharmacy Wales

Supporting documents:

Minutes:

9.1a The Committee noted the additional information from Community Pharmacy Wales in relation to the inquiry into the use of antipsychotic medication in care homes.

9.2

Letter from the Cabinet Secretary for Health, Well-being and Sport regarding the upcoming Committee inquiry into suicide prevention

Supporting documents:

Minutes:

9.2a The Committee noted the letter from the Cabinet Secretary for Health, Well-being and Sport in relation to the upcoming Committee inquiry into suicide prevention.

9.3

Letter from the Chair of the Public Accounts Committee regarding the NHS Finance (Wales) Act 2014

Supporting documents:

Minutes:

9.3a The Committee noted the letter from the Chair of the Public Accounts Committee regarding the NHS Finance (Wales) Act 2014.

10.

Motion under Standing Order 17.42 to resolve to exclude the public from the remainder of the meeting

Minutes:

10.1 The Committee agreed the motion.

(14.20 - 14.35))

11.

Use of anti-psychotic medication in care homes - consideration of evidence

Minutes:

11.1 The Committee considered the evidence given during items 2, 3, 6, 7 and 8 of the meeting.